Indian Journal of Animal Research
Chief EditorK.M.L. Pathak
Print ISSN 0367-6722
Online ISSN 0976-0555
NAAS Rating 6.50
SJR 0.263
Impact Factor 0.4 (2024)
Chief EditorK.M.L. Pathak
Print ISSN 0367-6722
Online ISSN 0976-0555
NAAS Rating 6.50
SJR 0.263
Impact Factor 0.4 (2024)
The protective role of silymarin against methotrexate-induced gastrointestinal injury
Submitted27-02-2016|
Accepted09-05-2016|
First Online 13-06-2016|
The protective effect of silymarin was investigated against methotrexate-induced GI injury. Forty Swiss-Albino mice were divided into 4 groups as control (Normal saline), methotrexate (15 mg/kg), silymarin (100 mg/kg) and methotrexate+silymarin (100 mg/kg + 15 mg/kg respectively). Blood and tissue samples were collected from the animals for biochemical and pathological examinations. Plasma, intestinal and gastric tissue malondialdehyde and TSA levels in methotrexate group were significantly higher than in control whereas whole blood glutathione concentration was lower in methotraxe group than in control. Plasma, intestinal and gastric TSA levels in methotrexate group were significantly increased compared to control and methotrexate+silymarin groups. Gastric tissue of methotrexate treated mice showed degeneration, necrosis, desquamation and widespread edema. However, these alterations were less severe in methotrexate+silymarin group. In conclusion, silymarin could be of therapeutic value against methotrexate-induced GI injury.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.